Wise RA, et al. - Seasonal variations in mortality and exacerbations in COPD patients were determined during the TIOtropium Safety and Performance In Respimat (TIOSPIR) trial. COPD exacerbations were 2-fold more likely to be reported during winter vs summer, respiratory deaths peaked in early spring. Thus, seasonal intensification of preventive treatments may impact COPD morbidity and mortality.